Skip to content
Bonalive
  • Deutsch
  • English
  • English US
  • Español
  • Français
  • Italiano
  • Português
Search
  • en-usChange location
      International
    • English (Int.)
    • Deutsch
    • Español
    • Français
    • Italiano
    • Português
    • United States
    • English (US)
Search

News

Indication of the quarter: Bone infection surgery

How to prevent the recurrence of benign bone tumors

S53P4 bioactive glass in surgery

3 ways to get to know Bonalive as a workplace

S53P4 bioactive glass remodeling

Pros and cons of 5 bone graft substitutes

4 innovations for an antibiotic-free future

Diabetic foot infections: Why it’s important to find new sustainable solutions

Cost-effective bone infection surgery – Bonalive® granules

S53P4 bioactive glass in healthcare – International Year of Glass

Bonalive joins Go Blue Campaign

New ways to prevent the recurrence of benign bone tumors

Spine surgery patient cases

Bioactive glass in spine surgery

Bone infection surgery publication overviews

Septic non-union whitepaper

Bonalive® granules in ENT product guide

Manufacturer Headquarters Distributor
Bonalive Ltd
Tel. +358 401 77 44 00
Biolinja 2, 20750 Turku, Finland
contact@bonalive.com
www.bonalive.com
Bonalive Inc
Tel. +1 (213) 378-2315
640 South San Vicente Blvd
Los Angeles, CA, 90048 USA
contactUS@bonalive.com
www.bonalive.com/us

Copyright © 2026 Bonalive Biomaterials Ltd.
Bonalive® Privacy Policy